3084 rounds · 1946 startups · 3572 investors
Person Invested in this round Raised it Closed a fund Mentioned
Amount confirmed Amount is an estimate
Australian drug developer Pharmaxis has won NASDAQ approval to trade its ADRs under ticker PXSLY, issuing no new shares; SEC registration is expected around 26 August 2005 before trading begins.
Also GBS Ventures·GBS Ventures
University of Queensland spinout Spinifex Pharmaceuticals landed $3.25 million from Symbiosis, GBS Venture Partners and Uniseed to advance its neuropathic pain therapy toward toxicology testing.
Also GBS Ventures·GBS Ventures·clinicalleader.com·bionity.com
ASX-listed medical device company Sunshine Heart appointed Melbourne heart transplant specialist Professor Don Esmore to its medical advisory board, which already includes academics from Penn State, Stanford and the Cleveland Clinic.
GBS Venture Partners closed its third life science fund at $145 million, exceeding its $120 million target, with backing from returning and new Australian institutional investors.
Surgeons in Auckland have placed the C-Pulse cardiac support device from Australian medtech Sunshine Heart into a patient for the first time, with further trial sites planned at Australian hospitals.
Sunshine Heart reported that surgeons at Auckland City Hospital implanted its C-Pulse heart device in a Class III heart failure patient, the procedure opening a trial of up to ten patients.
Melbourne drug-discovery firm Cortical has won an AusIndustry-administered federal R&D Start grant of $3.03 million, funding early clinical testing of its MIF-antagonist treatment candidate for inflammatory conditions.
Also GBS Ventures
Interview with Team Timbuktu founder Rhianna Knight on building an eco-friendly apparel brand, looking back at the crowd campaign that funded her first collection and teasing another to grow the range.
Podcast interview in which Team Timbuktu founder Rhianna Knight recounts launching a sustainable activewear label, validating it through crowdfunding, and her approach to ethical manufacturing and annual sustainability reporting.
Folklore Ventures founder story recalling its seed backing of Manuri Gunawardena's clinical trial matching startup HealthMatch, plus follow-ons in its Series A and December 2020 Series B alongside Square Peg.
A Perth company received a government spaceport establishment grant to assess sites and develop a business case for Western Australia's first spaceport facility.
Transcelestial raised an undisclosed new round co-led by NTT Finance and Paspalis Capital, with several other investors participating, taking its total funding to USD 30.7 million as it expands laser communications in Japan and Australia.
Microsoft partner Engage Squared has received investment from Alceon to build its AI, data and agent capabilities across APAC; the undisclosed sum is the first deal from Alceon's newly launched private equity fund.
Nexsen's investor page invites applications for its IPO under an August 2025 prospectus lodged with the corporate regulator; the share sale has not completed, so no funding is recorded.
M&A database entry recording Oneflare's 2018 acquisition of home services booking platform Urban You, its third Australian internet software deal, following its 2015 purchase of Word Of Mouth Online.
CBS News broadcasts Margaret Brennan's conversation with Hugging Face's co-founder and chief executive about a breach of the company's systems by an autonomous agent arising from an OpenAI-trained model.
Lender Funding has hired Lauren Severino and Sam Hermon as business development managers for New South Wales, expanding its BDM team to five amid growth in bridging and construction lending across the state.
The university assessment platform has raised new backing co-led by SEEK Investments and Glitch Capital, which it will use to enter the American market.
Sales-coaching AI startup Hupo has announced a $10 million Series A, with DST Global Partners leading and four earlier backers returning for the round.
FaBA profiles My PlantCo, Mei Yong's venture turning Australian oats into foods like Oat Rice, describing a $5.6 million FaBA project with GRDC co-investment now advancing the Real Oats range toward commercialisation.
A public-interest profile arguing Starward Whisky markets Melbourne independence while omitting its 2023 acquisition by UK multinational Diageo, with profits flowing overseas.
RentBetter republishes a Balance the Grind interview in which founder and CEO Jeremy Goldschmidt describes his daily routine and mentions the proptech platform's recent funding round.
Nurture Her speaker page profiling Vinomofo's chief executive, covering the wine e-commerce firm's growth since 2011, overseas expansion, a US partnership and industry awards.
Sydney-based NFT gaming firm Immutable has secured $200 million in new backing spearheaded by Singapore's Temasek, valuing the company at $2.5 billion; Tencent, Mirae Asset, ParaFi Capital and Declaration Partners also joined.
Also cryptobriefing.com·checkcryptonews.com·TechCrunch Australia
Listed investor Chapmans announces a $1.5 million placement for SaaS firm Rision, taking a $300,000 direct stake with options to become largest shareholder; background recalls Rision's 2016 acquisition of RosterCloud.
Pay-equity software startup EvenBetter.ai has landed a half-million-dollar investment from Shearwater Capital ahead of next month's launch, as new Australian gender pay reporting rules take effect.
Decidr's co-CEO argues enterprise AI fails without rich context, framing the firm's Sugarwork and Rumi acquisitions as pairing workflow mapping with continuous capture of meeting knowledge to feed its orchestration platform.
Trampoline presents Vitality Capital Partners, a fund of funds giving its members exposure to leading Asia-Pacific climate-tech managers through primary commitments plus co-investments, curated by Keshav Puri and Ayush Kapila.
Sydney Seed Fund launches with Odra Venture and Red Queen Fund to back Australian startups, opening applications for first investments; parent Odra Venture cites over $95m committed.
Sydney Seed Fund, a new vehicle from Odra Venture and Red Queen Fund, announces its Australian launch, aiming to deploy $40 million into an initial batch of 10–20 startups.
Exto Partners markets a new evergreen vehicle offering wealthy investors entry to top private AI firms through secondaries; no committed capital, target, or close is stated.
News page from growth investor Sundance Growth listing investments in five software companies, three portfolio acquisitions, and the $125 million close of its maiden fund, reached at its cap within about a month.
Innovation Victoria launches, merging Breakthrough Victoria and LaunchVic; Geoff Tarrant chairs the board, Monique Conheady deputises and Rod Bristow is CEO; Tarrant co-founded Payapps, bought by Autodesk in 2024.
Also Australian FinTech
Breakthrough Victoria's page announces Innovation Victoria, a new Victorian entity combining Breakthrough Victoria and LaunchVic from early July, with Rod Bristow as CEO, existing programs and investments continuing and both chairs stepping down.
Skalata Ventures unveils its rebrand to A Tall Order, restating its first-cheque AI investing thesis with cheques up to A$1M and announcing that its Fund III is now raising.
Venture firm Skalata rebrands itself as Tall Order, a first-money-in backer of AI-native operators, and invites investors into Fund III, citing top-quartile performance of its two earlier funds.
Quadrant Private Equity is about to complete its biggest-ever buyout fund, a $1.24 billion raise; the piece notes rival PEP's $2.5 billion close and recalls Quadrant's sales of APM and QScan.
Hedge fund firm Schonfeld is reported to be targeting a new quantitative vehicle of around a billion dollars, described alongside its existing multi-strategy platform, past performance and recent job cuts. Nothing is stated as committed.
Blackstone has finished gathering $8bn for its latest commercial property debt vehicle, BREDS V, which will buy loans and originate new ones spanning North America, Europe and Australia as banks retreat from property lending.
Brookfield posted record third-quarter results, finalised a $20bn transition fund, agreed to buy the rest of Oaktree, completed its Angel Oak purchase, and won approval to take over insurer Just Group.
Advent International has finished raising its tenth flagship buyout fund, GPE X, hitting a $25 billion hard cap in under six months; with Advent Tech II, combined commitments top $30 billion.
GI Partners wrapped the initial raise for its tech and science real estate fund, gathering $1.45 billion in commitments above its hard cap to buy data centre and life science properties in US markets.
A year after its previous flagship vehicle hit an $11bn ceiling, Apax Partners is chasing a bigger fund, while US pension minutes reveal new commitments and the firm moves to take control of Alcumus.
Biotech Cincera Therapeutics debuts with A$7 million in committed venture backing provided by the Medical Research Commercialisation Fund.
Playground Global has gathered $410m for a fresh pool of capital aimed at speeding scientific and deep-technology ventures toward real-world impact.
Denteric, a biotech spun out of an oral health research program, has raised $14 million for a gum disease vaccine, in a round led by the Biomedical Translation Fund with CSL also taking part.
Also denteric.com
NEA is reportedly raising close to $7bn split between an early-stage fund and a growth fund, abandoning its longtime single multistage fund approach, according to the piece.
Axion founder Daniel First announces a $37 million Series B with Salesforce Ventures leading, lifting total raised to $64 million, and describes the company's AI platform for resolving product quality issues in manufacturing.
Also axion.com
Hayfin's fourth direct lending vehicle has gathered more than its $6.6 billion target from backers including a San Antonio pension fund, with total capital expected near its €7 billion cap by year end.